Hawksen Soft Capsule (Naproxen)

Adult dose

1. Rheumatoid arthritis, osteoarthritis, ankylosing spondylitis Naproxen: 250-500 mg (1-2 capsules) orally, twice a day (every 12 hours). 2. Acute gout Initial dose: 750 mg (3 capsules) orally, then 250 mg (1 capsule) every 8 hours until the attack subsides. 3. Skeletal muscle disorders, postoperative pain, post-extraction pain, dysmenorrhea, tendinitis, bursitis Initial dose:

This medication may cause gastrointestinal bleeding in individuals who regularly consume more than three glasses of alcohol a day, so it is important to consult a doctor or pharmacist. This medication can increase the risk of cardiovascular events such as myocardial infarction or stroke, so patients with cardiovascular diseases or risk factors should take special care. It may also result in serious gastrointestinal adverse reactions such as gastrointestinal bleeding, ulcers, and perforation, especially in the elderly or those on prolonged treatment. Patients with serious conditions such as peptic ulcers, severe blood disorders, liver dysfunction, cardiac failure, kidney dysfunction, or hypertension should not take this medication, nor should those with hypersensitivity to its components. Patients with a history of peptic ulcers or bleeding tendencies, those with weakened liver or kidney function, hypertensive patients, and asthmatic patients should use this medication cautiously, and the elderly should also take care. Various side effects may occur during the use of this medication, including hypersensitivity, gastrointestinal disturbances, blood disorders, liver dysfunction, kidney disorders, neuropsychiatric symptoms, skin complications, auditory and visual impairments, and if any unusual symptoms arise, immediate consultation with a doctor is advised. This medication should be taken at the lowest effective dose for the shortest duration possible, and regular blood tests and liver function tests should be conducted for those on long-term treatment. In particular, children with a high fever, the elderly, and frail patients should be closely monitored after administration. This medication may interact with other non-steroidal anti-inflammatory drugs, certain anti-epileptic medications, beta-blockers, ACE inhibitors, diuretics, aspirin, lithium, anticancer drugs, and anticoagulants, so be sure to inform your healthcare provider of any other medications being taken. It should not be taken during pregnancy, especially in the later stages, and caution is advised after 20 weeks of pregnancy as it may affect fetal kidney function. Women who are breastfeeding should not take this medication as it can pass into breast milk and harm the newborn. It is advisable not to administer this medication to infants under 2 years of age due to established safety concerns, and it should be cautiously administered to children and the elderly at the lowest effective dose. In case of overdose, symptoms such as drowsiness, dyspepsia, and vomiting may occur, requiring immediate emergency treatment. This medication should be stored out of reach of children, and caution should be taken not to transfer it to another container, as this could adversely affect its quality.

Serious side effects

• Hives
• severe swelling (edema)
• chest tightness
• difficulty breathing
• cold sweat
• pallor
• gastrointestinal bleeding
• peptic ulcers
• perforation
• agranulocytosis

Mild side effects

• Occasionally
• rash
• itching
• discomfort in the upper abdomen
• stomach pain
• abdominal pain
• nausea
• vomiting
• loss of appetite
• dyspepsia

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is best to keep it at room temperature between 1 to 30 degrees Celsius.

Appearance

Orange transparent oval soft capsules containing a colorless to light orange transparent content

Package unit

10 capsules/PTP